Clinical Trials
4 trialsNCT03768063 2026-04-28
IMbrella B
Hoffmann-La Roche
Phase 3 Active not recruiting
NCT02873962 2026-04-01
A Phase II Study Of Nivolumab/ Bevacizumab/Rucaparib
Dana-Farber Cancer Institute
Phase 2 Active not recruiting
NCT04624178 2025-11-20
A Study of Rucaparib and Nivolumab in People With Leiomyosarcoma
Memorial Sloan Kettering Cancer Center
Phase 2 Active not recruiting
NCT03522246 2025-06-24
ATHENA
pharmaand GmbH
Phase 3 Active not recruiting